Skip to content

Blackmail, violence and stigma restrict access to sexual health services for gay men, Global Health and Rights Study reports

Compassionate access to new hepatitis C drugs an "emergency" for European patients

Second-generation HCV protease inhibitor simeprevir pushes triple therapy cure rate up to 80%

Second-generation protease inhibitor faldaprevir cures up to 80% of hepatitis C

Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis

Hep C quad regimens quashed, but some components go forward

Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care

A majority of HIV-positive gay men in Dutch survey take their viral load into consideration if having unprotected sex

Researchers stop the only current HIV vaccine efficacy trial